Business Context and Reporting Period
Company: The Scotts Miracle-Gro Company (SMG)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended December 27, 2025 (Fiscal Q1 2026)
Business Overview: SMG manufactures and markets lawn and garden care products, primarily in North America. The business is highly seasonal, with over 75% of annual sales occurring in the second and third fiscal quarters. The Hawthorne business has been classified as a discontinued operation and held for sale.
Key Financial Metrics
| Metric (in millions) | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Sales | $354.4 | $366.6 |
| Gross Margin | $88.7 (25.0%) | $88.5 (24.1%) |
| Loss from Operations | $(21.8) | $(45.8) |
| Net Loss from Continuing Operations | $(47.8) | $(66.1) |
| Loss from Discontinued Operations | $(77.2) | $(3.4) |
| Total Net Loss | $(125.0) | $(69.5) |
| Diluted EPS (Total) | $(2.16) | $(1.21) |
| Cash Used in Operating Activities | $(370.4) | $(445.3) |
| Cash and Cash Equivalents (End of Period) | $8.3 | $5.7 |
| Total Debt | $2,542.3 | $2,706.7 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 3.3% to $354.4 million, driven by a 5.2% volume/mix decrease (lower fertilizer, grass seed, and controls sales) partially offset by a 1.8% pricing increase.
- Discontinued Operations Impact: A significant non-cash pre-tax charge of $104.8 million was recorded for the Hawthorne business (classified as held for sale), resulting in a $77.2 million loss from discontinued operations compared to $3.4 million in the prior year.
- Improved Operating Performance: Loss from operations improved by 52.4% to $(21.8) million, driven by a higher gross margin rate (25.0% vs 24.1%), lower SG&A expenses, and significantly reduced impairment/restructuring charges ($3.1 million vs $17.9 million).
- Interest Expense Reduction: Interest expense decreased 19.8% to $27.2 million due to lower average borrowings and a reduced weighted average interest rate.
- Inventory Build: Inventories increased to $846.7 million from $542.7 million at the end of the prior fiscal year, reflecting seasonal production for the spring selling season.
Guidance, Outlook, and Risks
- Strategic Shift: The Hawthorne business is held for sale with an expected sale within 12 months. Results are now reported as discontinued operations.
- Liquidity and Debt: The company entered a new $2.0 billion credit facility (Seventh A&R Credit Agreement) in November 2025. As of December 27, 2025, borrowing availability was $979.8 million. The leverage ratio was 4.03 (max 5.00) and interest coverage ratio was 5.05 (min 3.00).
- Share Repurchases: A new $500.0 million share repurchase program was authorized on December 19, 2025, with no expiration date. No repurchases have occurred under this new authorization.
- Risks: Management cites macroeconomic conditions (inflation, interest rates), geopolitical uncertainty, and supply chain disruptions as key risks. The company is also defending against securities litigation regarding alleged misstatements about inventories and sales.
- Outlook: No specific numerical guidance for the full fiscal year was provided in this filing. Management expects cash flows from operations and borrowings to meet debt service and working capital needs.
Investor Verification Checklist
- Discontinued Operations: Verify the timeline and potential proceeds from the sale of the Hawthorne business to understand the impact on future earnings.
- Inventory Levels: Monitor the high inventory balance ($846.7M) relative to sales volume to assess potential future write-downs or obsolescence risks.
- Debt Covenants: Confirm continued compliance with the new credit agreement's leverage (4.03) and interest coverage (5.05) ratios, especially given the seasonal nature of cash flows.
- Legal Proceedings: Track the status of the consolidated securities litigation (In re The Scotts Miracle-Gro Company Securities Litigation) regarding inventory and sales disclosures.
- Seasonality: Recognize that Q1 results are not indicative of full-year performance due to the heavy concentration of sales in Q2 and Q3.